test

Steve R. Bailey

@Frazier Life Sciences Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$2.495BTotal holdings53
Assets growth rate16.72%Assets growth rate (2-Q avg)3.46%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Frazier Life Sciences Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 53 positions.

Assets under management

The assets under management (AUM) of Frazier Life Sciences Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.495B in assets, with a quarterly growth rate of 16.72% and a 2-quarter average growth rate of 3.46%. The portfolio is managed by Steve R. Bailey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
RAREUltragenyx Pharmaceutical In
Recent Activity
Increased 49.11%
1.42%
$35.203M
633,715 shares@ $55.55 avg price
SVRASavara Inc
Recent Activity
1.39%
$34.587M
8.157M shares@ $4.24 avg price
CGONCg Oncology Inc
Recent Activity
1.17%
$29.052M
770,000 shares@ $37.73 avg price
RCKTRocket Pharmaceuticals Inc
Recent Activity
Decreased -4.84%
1.1%
$27.44M
1.486M shares@ $18.47 avg price
TRVITrevi Therapeutics Inc
Recent Activity
0.99%
$24.653M
7.381M shares@ $3.35 avg price
MREOMereo Biopharma Group Plc
Recent Activity
Increased 15.83%
0.84%
$20.952M
5.098M shares@ $4.12 avg price
SLNSilence Therapeutics Plc
Recent Activity
0.84%
$20.881M
1.149M shares@ $18.18 avg price
ASNDAscendis Pharma A S
Recent Activity
New Position
0.8%
$19.908M
133,333 shares@ $149.31 avg price
HLVXHillevax Inc
Recent Activity
0.75%
$18.686M
10.617M shares@ $1.76 avg price
MRUSMerus N V
Recent Activity
0.75%
$18.64M
373,100 shares@ $49.96 avg price